Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych.

Slides:



Advertisements
Similar presentations
Drugs acting on the CNSI
Advertisements

Other Medicines. Andrenergic Antagonists (Blockers) Bind to receptor site but do not cause an action Bind to receptor site but do not cause an action.
Antiparkinsonian Agents Ch 14. Parkinson’s Disease Progressive, y.o. d/t imbalance between dopamine & acetylcholine Symptoms: Slowed movement.
Monoamine oxidase inhibitors Monoamine Oxidase Inhibitors (MAOIs) are a class of powerful antidepressant drugs. They are particularly effective in treating.
Module 4: Interaction of. Objectives To be aware of the possible reasons why dual diagnosis occurs To be aware of the specific effects of substances on.
Medication used in Mental Health August2013GSHarnisch.
Neuropathophysiology Synaptic Transmission & Neurotransmitters September 24, 2012 Ashkan Afshin.
Drugs used in affective disorders: antidepressants
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 17 Psychotherapeutic Agents.
Types of Treatment.
Affective and Anxiety Disorders. What are affective disorders? Disorders of mood found throughout history unipolar or major depression bipolar or manic.
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
1 ANTI DEPRESSANT DRUGS. 2 3 DEPRESSION INTENSE FEELINGS OF SADNESS INTENSE FEELINGS OF SADNESS HOPELESSNESS HOPELESSNESS DESPAIR DESPAIR INABILITY TO.
Antidepressants & Neuroleptics Lesson 20. Unipolar Depression n Major Depressive Disorder n Extreme sadness & despair l extent & duration important n.
Management Of Depressive Disorders Pharmacologic Treatments For Depression Copyright © World Psychiatric Association.
 characterized by positive and negative symptoms ◦ positive symptoms – those that can be observed; ex. hallucinations ◦ negative symptoms – absence of.
Introduction to the Biological Basis for Understanding Psychotropic Drugs.
1 Clinical Toxicology & Pharmacology Newcastle Mater Misericordiae Hospital Risks of Psychotropics.
PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.
Serotonin Syndrome SS life threatening emergency from excess CNS 5HT (serotonin) caused by combining 5HT enhancing drugs or giving SSRIs too close to discontinuation.
PSYCHIATRIC DRUGS Chapter 13. Psychiatric Drugs  Treat mood, cognition, and behavioral disturbances associated with psychological disorders  Psychotropic.
Treating Behavioral and Psychological Symptoms of Dementia (BPSD) Kuang-Yang Hsieh, M.D. ph.D. Department of Psychiatry Chimei Medical Center.
Maryam Tabatabaee M.D Assistant professor of psychiatry.
I CAN Explain psychopharmacology Describe properties, use, and side effects of: Antipsychotic Medications Anti-depressants Anti-anxiety stimulants Copyright.
Pharmacotherapy in Psychotic Disorders. Antipsychotic drugs Treat the symptoms of the disorder Do not cure schizophrenia Include two major classes: –
Erin Kibbey, RN, BS, CCRN Psychopharmacology. ›From a historical perspective, reflect on how psychopharmacology has changed mental health nursing ›Explore.
Anxiety A state of tension in response to real or imagined stress or danger situations. Anxiety may manifest itself as Psychic or mental state. Somatic.
ANTIDEPRESSANTS New Antidepressants.
Drugs used in Anxiety & Panic Disorders
Antipsychotic agents By S.Bohlooli PhD.
Mood Disorders Lesson 24.
Trazodone Mianserin Mirtazapine Tetracyclic Antidepressants Noradrenergic & Specific Serotonergic Antidepressants (NaSSAs) Serotonin Antagonists & Reuptake.
Isahel N. Alfonso, R.N.  Selective Serotonin Reuptake Inhibitor (SSRI) Fluoxetine Fluvoxamine Paroxetine Sertraline Citalopram  Tricyclic Compound (TCA)
Drugs used in Depression- New groups By Prof. Yieldez Bassiouni.
بسم الله الرحمن الرحيم Dr: Samah Gaafar Hassan Al-shaygi.
 Disorders of mood ◦ found throughout history  unipolar or major depression  bipolar or manic depression.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 05Psychopharmacology.
Anxiolytics and Other Agents Used to Treat Psychiatric Conditions
for MHD & Therapeutics is proud to present And Now Here Is The Host... Insert Name Here.
Case study Which antidepressant Dr. Matthew Miller.
Antidepressant drugs. Depression: is a disorder of mood rather than disturbance of thought or cognition. It is postulated that depression is due to deficiency.
Anti-depressants Dr. Sanjita Das Range Tricyclics Tetracyclics Selective serotonin reuptake inhibitorsSelective serotonin reuptake inhibitors SSRI Serotonin.
Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych.
 Disorders of mood ◦ found throughout history  unipolar or major depression  bipolar or manic depression.
Drugs used in the treatment of affective disorders Dr. Vidumini De Silva.
Anxiolytic , Sedative and Hypnotic Drugs
Psychotropic Medications G505: Individual Appraisal.
Biomedical Therapies. Antipsychotic Drugs Antipsychotic drugs (like Thorazine, Mellaril, and Haldol) are used to gradually reduce psychotic symptoms,
 : Monoamine hypothesis of depression asserts that depression is caused by functional insufficiency of monoamine neurotransmitter (norepinephrine, serotonin.
ANTIDEPRESSANTS Drugs which can Elevate Mood (Mood Elevators)
By dr.safeyya alchalabi
Drugs used for anxiety and panic disorders
Drugs used for anxiety and panic disorders
Ch. 13: Biomedical Therapy: Biological Approaches to Treatment
Psychiatric Medications
UNIT 19 Psychotropic Agents.
Drugs used in Depression- Prof. Yieldez Bassiouni
Drugs used in Depression- Prof. Yieldez Bassiouni
Psychiatric Drugs Chapter 13.
Antidepressants Biology/Psychology 3506.
ِِAntipsychotic Drugs
Spinrad/Psychology Antipsychotic Drugs.
School of Pharmacy, University of Nizwa
School of Pharmacy, University of Nizwa
PHARMACOTHERAPY - I PHCY 310
Drugs used in Depression- Prof. Yieldez Bassiouni
Neuroleptic drugs.
Drugs used in Depression-
Antipsychotics.
Drugs Used in Depression (New group)
Presentation transcript:

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych

A. Heterocyclic antidepressants: (tricyclic and tetracyclic ), e.g.amitryptaline,imipramine. B. Monoamine oxidase inhibitors(M.A.O.I), e.g.phenelzine. C. Selective serotonin reuptake inhibitors SSRI’s,e.g. flouxetene, paroxetene, fluvoxamine. D. Atypical antidepressants. E. Sympathomemetic agents. Antidepressants do not elevate normal mood and do not have any abuse potential except amphetamine antidepressants have other clinical uses in medicine and psychiatry.

Action: A. heterocyclic: 1. exert it’s antidepressant action by blocking the reuptake of norepinephrine and serotonin in the synapse so increase their availability and improve mood. 2. also block muscirinic,acetylcholine and histamine receptors causing anticholenergic effects, sedation and weight gain, dangerous in overdose. B. SSRI’s : 1. selectively block the reuptake of serotonin, have limited effects on NE, dopamine, histamine,and acetylcholine. 2. because of their selective action cause fewer side effects and are safe in overdose than heterocyclic's and MAOI’s.

c. MAOI’s: 1. irreversibly limit the activation of MAO, so increase the availability of norepinephrine and serotonin in the synapse and improve mood. 2. MAO metabolize tyramine in the GIT so that food rich in tyramine e.g. aged cheese,chicken, beef liver, smoked meets or fish, broad beans, beer and wine) or sympathomemetic drugs e.g. epinephrine, methylphenidate(retalin) can increase the level of tyramine and cause hypertensive crisis may lead to stroke or death. 3. MAOI’s and SSRI’s if used together can cause another life threatening drug-drug interaction (serotonin syndrome)marked by autonomic instability, hyperthermia, convulsions, coma and death.

Problems encountered with heterocyclic's:  Anticholenergic side effects: dry mouth, blurred vision, constipation, glaucoma, retention of urine, delirium.  Noradrenergic:posrural hypotension, sedation.  Dysrhythmia  Low fit threshold.  Inappropriate ADH.  An orgasmia.  Abnormal liver function.  Weight gain  Cardiac toxicity in overdose.

Problems of MAOI’s:  Cheese reaction…….hypertensive crisis.  Drowsiness.  GIT disturbances.  Headache.  Postural hypotension.  Drug interaction (opiate, anesthetic’s, sympathomemetic’s).  Liver damage. Problems with SSRI’s:  GIT, nausea, vomiting, diarrhea, appetite loss.  Agitation and insomnia.  Headache.  Inappropriate ADH secretion.  Cost (more than others).

Choosing an antidepressant:  Clinical picture.  Need for sedation.  C.V.D.  Tolerance of side effects.  Cost

Lithium: Antimanic (need 5-6 days) and mood stabilizer, and augmentation of antidepressant. Mechanism of action: rapidly absorbed and replaces sodium and potassium in the cells, this alters the flux of Mg, Ca across cell membrane, lithium is filtered by the kidney and only partially reabsorbed. Mechanism of action of lithium:  Changing the concentration of Na and K within the cell  Changing the dynamic of Mg and Ca.  Changing the responsiveness of Na/K ATpase.  Changing the permeability of blood brain barrier.  Changing the sensitivity of the dopamine receptors.  Decreasing uptake of noradrenalin into cells.  Altering sensitivity of beta adrenoceptors.

The physical work up for lithium:  Urea and electrolytes.  Createnin clearance.  Full blood count.  Thyroid function test.  ECG.  Pregnancy test. Therapeutic level mmol/l. Side effects of lithium: GIT side effects, tremor, weight gain, muscle weakness, leucocytosis, hypothyroidism, ECG changes, nephrogenic diabetes insipidus 5%, ataxia, nystagmus, delirium, coma, death. Other mood stabilizers: Na-valproate and carbamazepine.

 The first effective drug to be used for the treatment of schizophrenia was chlorpromazine then a wide range of drug with differing potency and side effect profile has been introduced it is better to become familiar with small range of these drugs that will cover differing situations.  The choice and dose depends on:  The severity  The required Sedation  The patient size  His medical condition.

 D2 receptor antagonism which can be found principally in the limbic system.  Most antipsychotics are non specific in thier site of action  The new antipsychotics are probably more D2 specific antagonist so it has better side effects profile

 Anti dopaminergic (extrapyramidal symptoms) mediated by D1 receptor.  Acute dystonia  Akathesia  Parkinsonism  Tardive dyskinesia  Amenorrhoea  Galactorrhoea

 Antiadrenergic  Postural hypotension  Sedation  Anticholinergic  Constipation  Blurred vision  Precipitating glaucoma  Urinary retention  Dry mouth

 Other side effects  Weight gain  Dysrhythmia  Low seizure threshold  Chlorpromazin is associated with photosensitivity and cholestatic jaundice and Neotropenia  Thioredazine in high doses can cause retinitis pimentosa

 Are highly selective D2 blockers so cause fewer extrapyramidal symptoms e.g Olanzapine and Clozapine  Benzodiazepine act by enhancing the action of GABA  Anxiolytics (long half life )  Hypnotics (short half life )

 Reduced pathological anxiety,agitation and tension but it is addictive  Should not be used more than one month  Should be avoided in those with personality problems and those with history of substance abuse.

 Benzodiazipine inhibit REM sleep and a rebound increase REM is seen when they are discontinued  Care must be taken not to be used regularly or long time  Avoid prescribing on discharge from hospital.

 Headache  Confusion  Ataxia  Dysartheria  Blurred vision  GI symptoms  Jaundice  paradoxical excitement  Loss of memory  Depression  can cause antero-grade amnesia  Affecting driving performance  In I.V may cause respiratory depression

 Short term use  Restrict to severe anxiety  To deal with a specific problem or event  Intermittent dosing  Lowest effective dose